Patents by Inventor Yulu LI

Yulu LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240134502
    Abstract: A speaking user selecting method and apparatus, an electronic device, a storage medium, a computer program product, and a computer program. The method comprises: receiving a first request sent by a first terminal device, the first request being used for determining a speaking user in a user group, wherein the user group comprises at least two users to be selected, and each user to be selected corresponds to one second terminal device; determining a random selection model corresponding to the first request, the random selection model being used for representing a policy for randomly determining a speaking user from the user group; and determining a speaking user from the at least two users to be selected according to the random selection model, and sending identification information of the speaking user to the first terminal device and the second terminal device.
    Type: Application
    Filed: December 28, 2023
    Publication date: April 25, 2024
    Inventors: Zhipeng TUO, Dongyun YANG, Jie LI, Qinyan ZHANG, Yulu WANG, Jinpeng SHI
  • Publication number: 20240076412
    Abstract: An isolated anti-CD47 antibody or fragment thereof has the ability of binding CD47 and competing with the binding of SIRPa to CD47, and comprises a heavy chain variable region comprising heavy chain complementarity determining regions HCDR1, HCDR2, and HCDR3; and a light chain variable region comprising light chain complementarity determining regions LCDR1, LCDR2, and LCDR3. A method for treating a disorder in which CD47 is overexpressed or upregulated in a subject, comprises using an isolated anti-CD47 antibody or fragment thereof having the ability of binding CD47 and competing with the binding of SIRPa to CD47. A bispecific antibody comprises a first antigen binding moiety that binds to human GPC3 (hGPC3); and a second antigen binding moiety that binds to human CD47 (hCD47).
    Type: Application
    Filed: January 5, 2022
    Publication date: March 7, 2024
    Inventors: Jianhua SUI, Kaixin DU, Wei CHEN, Yulu LI, Juan LIU